SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
480Congrads holders!!! This is a NICE deal. Something nice to see in this terriblkenhott-12/12/2008
479$240 MM upfront from BMY for 2 drugs. Wonder if the buyer yesterday midday knewRobohogs-12/12/2008
478Exelixis Reports Positive Phase 1 Data for XL228 at ASH Annual Meeting SAN FRAIan@SI-12/8/2008
477Encouraging Ph 1 results in MF. Current standard of care has been regular bloodIan@SI-12/7/2008
476UPDATE 1-<b>Exelixis to co-develop cancer therapy with Bristol</b> idos-11/24/2008
475Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patkeokalani'nui-11/20/2008
474Exelixis Research Collaboration With Bristol-Myers Squibb Extended Business Wiremopgcw-11/8/2008
473decent inside buy by director Stelios..mopgcw-10/30/2008
472I just don't understand what's driving price movements in these biotechsIan@SI-10/29/2008
471Piper downgraded EXEL and several other biotechs after the close. No doubt theytuck-10/29/2008
470This was worth a loss of $0.02 for the day... 08:47 am Exelixis: Should have a Ian@SI-10/28/2008
469gsk has been making a big push into antibodies. Fairly or not I think kinase inhrkrw-10/28/2008
468CC transcript: seekingalpha.commopgcw-10/28/2008
467But i have to wonder about GSK's analysis and rationale...it seems odd when mopgcw-10/28/2008
466Seeking Alpha: Buying More Exelixis in the Post - GlaxoSmithKline Era by: Ohad mopgcw-10/28/2008
465Exelixis Announces Third Quarter 2008 Financial Results Monday October 27, 4:10 mopgcw-10/27/2008
464GSK development partnership over. Exelixis Retains Rights to Develop and Commerkenhott-10/23/2008
463<b>Exelixis Reports Positive Phase 1 Data for PI3K/mTOR Inhibitor XL765 atIan@SI-10/22/2008
462Ok, I'll post this one today... :-) <b>Exelixis Will Have 15 PresentIan@SI-10/16/2008
461No-one posted this yesterday: Exelixis Submits Diligence Report for Cdc7 Inhibinigel bates-10/16/2008
460Exelixis Files IND Application for XL888 Oct 2, 2008 16:05:01 (ET) SOUTH SAN FLJM-10/2/2008
459From SeekingAlpha: Exelixis: A Platform Company for Oncology by: Ohad Hammer pomopgcw19/4/2008
458Buying opp IMO....Of course I got in pretty close to the lows so even todays droim a survivor-8/6/2008
457The market must be touchy if these guys can send the stock down 15%... Canaccormopgcw-8/6/2008
456Oct date with GSK re XL184 6:07AM Exelixis notifies GlaxoSmithKline of proof-ofIan@SI-7/28/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News